Vor Biopharma Inc. (VOR)
NASDAQ: VOR · Real-Time Price · USD
14.97
-0.04 (-0.27%)
At close: May 29, 2026, 4:00 PM EDT
14.89
-0.08 (-0.56%)
After-hours: May 29, 2026, 7:04 PM EDT
Vor Biopharma Market Cap
Vor Biopharma has a market cap or net worth of $811.16 million as of May 29, 2026. Its market cap has increased by 3,960.63% in one year.
Market Cap
811.16M
Enterprise Value
322.57M
1-Year Change
3,960.63%
Ranking
Category
Stock Price
$14.97
Market Cap Chart
Since the IPO on February 5, 2021, Vor Biopharma's market cap has decreased from $1.30B to $811.16M, a decrease of -37.56%. That is a compound annual growth rate of -8.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 28, 2026 | 813.33M | 60.59% |
| Dec 31, 2025 | 506.46M | 266.35% |
| Dec 31, 2024 | 138.24M | -9.38% |
| Dec 29, 2023 | 152.56M | -65.05% |
| Dec 30, 2022 | 436.57M | 0.75% |
| Dec 31, 2021 | 433.30M | -66.64% |
| Feb 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Avalo Therapeutics | 847.88M |
| Odyssey Therapeutics | 845.36M |
| Evommune | 840.31M |
| Theravance Biopharma | 835.67M |
| Aura Biosciences | 827.25M |
| Phathom Pharmaceuticals | 819.72M |
| CytomX Therapeutics | 807.68M |
| Omeros | 806.99M |